Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022567

Expand all

VIIBRYD (VILAZODONE HYDROCHLORIDE)
10MG
Marketing Status: Prescription

Active Ingredient: VILAZODONE HYDROCHLORIDE
Proprietary Name: VIIBRYD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022567
Product Number: 001
Approval Date: Jan 21, 2011
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

VIIBRYD (VILAZODONE HYDROCHLORIDE)
20MG
Marketing Status: Prescription

Active Ingredient: VILAZODONE HYDROCHLORIDE
Proprietary Name: VIIBRYD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022567
Product Number: 002
Approval Date: Jan 21, 2011
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

VIIBRYD (VILAZODONE HYDROCHLORIDE)
40MG
Marketing Status: Prescription

Active Ingredient: VILAZODONE HYDROCHLORIDE
Proprietary Name: VIIBRYD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022567
Product Number: 003
Approval Date: Jan 21, 2011
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information